FAM19A5 rs807567: Exploring the Neurobehavioral Variant

What each genotype means

Genomic Context and Structure of rs807567

The genetic variant rs807567 is an intronic single nucleotide polymorphism located on chromosome 22 within the genomic locus of the FAM19A5 gene. In standard genomic reference builds, rs807567 represents an exchange between cytosine (C) and thymine (T) alleles. Because this variation resides within a non-coding sequence rather than an exon, it does not directly alter the amino acid sequence of any produced protein. Instead, non-coding polymorphisms like rs807567 are generally hypothesized to influence regulatory mechanisms, such as gene expression levels, splicing efficiency, or chromatin structure. The National Center for Biotechnology Information catalogs the marker under dbSNP entry rs807567, tracking its chromosomal coordinates, surrounding sequence context, and submission history across diverse worldwide sequencing cohorts. Understanding its exact location helps researchers evaluate whether the variant directly impacts regional genomic function or simply tags nearby regulatory elements through linkage disequilibrium.

The Biological Role of FAM19A5

The FAM19A5 gene, also known as TAFA chemokine like family member 5 (TAFA5), encodes a secreted protein belonging to the TAFA/FAM19A family. This family of proteins is predominantly expressed in the central nervous system, where they are believed to function as neurokines or brain-specific chemokines. Modern neurobiological studies demonstrate that FAM19A5 participates in synaptic maintenance, synapse elimination, and neural circuit development. Research in model organisms suggests that alterations in FAM19A5 levels can disrupt dendritic spine maturation, alter synaptic density, and modulate neurobehavioral responses such as fear conditioning and locomotor activity. Furthermore, laboratory studies have examined FAM19A5 as a potential modulator of neurodegenerative cascades, noting changes in human cerebrospinal fluid concentrations during normal aging and neurodegenerative processes. Because of its pivotal role in fine-tuning brain synapses, variations near or within the FAM19A5 sequence have attracted sustained interest from psychiatric geneticists.

Trait Associations and Evidence Evaluation

Genome-wide association studies (GWAS) have analyzed rs807567 in relation to multiple neurobehavioral and neurological traits, including cognitive performance, behavioral phenotypes, and susceptibility to complex conditions such as depression and attention-related traits. However, according to public repositories such as the GWAS Catalog, evidence linking rs807567 definitively to a clinical condition remains limited. The statistical correlations discovered in population cohorts involve very modest effect sizes, typical of complex polygenic traits where thousands of independent genetic variants collectively influence an outcome. Furthermore, some reported signals reflect broad genomic regions rather than direct causal evidence for rs807567 itself. Clinically oriented databases like ClinVar do not classify this polymorphism as a high-penetrance pathogenic mutation. Consequently, the variant should be understood as an exploratory scientific association rather than an established clinical biomarker.

Population Diversity and Allele Frequencies

According to population aggregation datasets, including gnomAD and the 1000 Genomes Project, rs807567 is a common variant observed across multi-ancestry populations. Both the C allele and the T allele circulate at notable frequencies worldwide, although exact minor allele frequencies vary moderately between ancestral groups such as individuals of European, African, East Asian, and Admixed American ancestry. Because the marker is prevalent in the general population, carrying one or two copies of either allele is entirely typical. Such widespread distribution underscores that neither allele is incompatible with normal human neurodevelopment or health. Comparative population genomics continues to map these distributions to ensure that association signals discovered in one ancestral background are not falsely assumed to exert the exact same statistical influence in diverse, unstudied populations.

Interpreting Your Results Responsibly

If you have reviewed personal genetic testing or research data and identified your rs807567 genotype, it is essential to frame the finding correctly. A single nucleotide polymorphism in a non-coding region of FAM19A5 cannot determine your cognitive abilities, mental health status, or future neurological trajectory. Human behavioral traits and neurological resilience emerge from complex interactions among hundreds of genes, alongside extensive environmental factors such as lifestyle, education, physical health, and social environment. Genomic data of this nature is intended purely for educational and investigative insight, not for medical diagnosis, risk prediction, or therapy selection. Individuals concerned about neurological symptoms, mood concerns, or psychiatric conditions should consult a qualified physician or genetic counselor rather than relying on individual consumer genotyping markers.

Frequently asked questions

Sources & further reading